Pharmcore Inc.

FDA Regulatory Profile

Pharmcore Inc. appears in FDA public data with 9 recalls, 0 510(k) clearances, 0 FDA inspections, and 0 compliance actions on record. Its most recent recall (D-1155-2018, Class II) was initiated on August 2, 2018.

Summary

Total Recalls
9
510(k) Clearances
0
Inspections
0
Compliance Actions
0

Recent Recalls

NumberClassProductDate
D-1155-2018Class IIIpamorelin 9 mg vial Lyophilized 1109 East Hallandale Beach Blvd. Hallandale Beach, FL 33009August 2, 2018
D-1152-2018Class IIHuman Chorionic Gonadotropin 6000 IU Vial Lyophilized 1109 East Hallandale Beach Blvd. Hallandale BeAugust 2, 2018
D-1148-2018Class IIHuman Chorionic Gonadotropin 11000 IU Vial Lyophilized 1109 East Hallandale Beach Blvd. Hallandale BAugust 2, 2018
D-1149-2018Class IIHuman Chorionic Gonadotropin 20000 IU Vial Lyophilized 1109 East Hallandale Beach Blvd. Hallandale BAugust 2, 2018
D-1150-2018Class IIHuman Chorionic Gonadotropin 2500 IU Vial Lyophilized 1109 East Hallandale Beach Blvd. Hallandale BeAugust 2, 2018
D-1154-2018Class IIMethylcobalamin 10 mg vial Lyophilized 1109 East Hallandale Beach Blvd. Hallandale Beach, FL 33009August 2, 2018
D-1147-2018Class IIHuman Chorionic Gonadotropin 5000 IU Vial Lyophilized 1109 East Hallandale Beach Blvd. Hallandale BeAugust 2, 2018
D-1151-2018Class IIHuman Chorionic Gonadotropin 4000 IU Vial Lyophilized 1109 East Hallandale Beach Blvd. Hallandale BeAugust 2, 2018
D-1153-2018Class IIIpamorelin 3 mg Lyophilized 1 vial 1109 East Hallandale Beach Blvd. Hallandale Beach, FL 33009August 2, 2018